LTFS
INMB icon

Ladenburg Thalmann Financial Services’s INmune Bio INMB Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Hold
100
– – ﹤0.01% 5199
2019
Q3 		$1K Hold
100
– – ﹤0.01% 5115
2019
Q2 		$1K Buy
+100
New +$1.01K ﹤0.01% 5109

Other funds holding INMB

FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
TPWA
TRUE Private Wealth Advisors Salem, Oregon $1.16B AUM 36.18% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Ladenburg Thalmann Financial Services's INMB Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its INmune Bio (INMB) position steady in Q4 2019 at 100 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5199.

Ladenburg Thalmann Financial Services first reported a position in INMB in Q2 2019 and has held it in 3 quarters since. 11 funds tracked by Wall St. Rank hold INMB as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 100 shares of INmune Bio worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its INmune Bio share count unchanged in Q4 2019.
  • INmune Bio made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5199 holding.
  • Ladenburg Thalmann Financial Services first reported a position in INmune Bio in Q2 2019 and has held it in 3 quarters since.
  • 11 funds tracked by Wall St. Rank held INmune Bio as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.